Griseofulvin vs. terbinafine in the treatment of tinea capitis
Egyptian Journal of Hospital Medicine [The]. 2017; 69 (8): 2992-2996
in English
| IMEMR
| ID: emr-190082
ABSTRACT
Background:
two oral antifungal agents, griseofulvin and terbinafine, have regulatory approval but it is unknown whether one has superior overall efficacy. Genus-specific differences in efficacy are believed to exist for the two agents. It is not clear at what doses and durations of treatment these differences apply
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Type of study:
Controlled clinical trial
Language:
English
Journal:
Egypt. J. Hosp. Med.
Year:
2017
Similar
MEDLINE
...
LILACS
LIS